|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Cash flow from operating activities: | |||||
| Net Income Loss | |||||
| Adjustment to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Fair value of vested stock options | |||||
| Stock options expense | |||||
| Restricted common stock expense | |||||
| Fair value of vested unrestricted common stock | |||||
| Modification cost of accelerated vesting of restricted common stock | |||||
| Accreted interest expense | |||||
| Adjustment to contingent earnout liability | |||||
| Resolute AI | |||||
| Scite | |||||
| Total adjustment to contingent earnout liability | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Prepaid royalties | |||||
| Accounts payable and accrued expenses | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Cash flow from investing activities: | |||||
| Purchase of property and equipment | |||||
| Payment for acquisition, net of cash acquired | |||||
| Resolute AI | |||||
| Scite | |||||
| Net cash used in investing activities | |||||
| Cash flow from financing activities: | |||||
| Proceeds from the exercise of stock options | |||||
| Common stock repurchase | |||||
| Payment of contingent acquisition consideration - Scite and FIZ | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for income taxes | |||||
| Non-cash investing and financing activities: | |||||
| Contingent consideration accrual on asset acquisition | |||||
| Common stock issued for Scite earnout payment | |||||
Loading...